A detailed history of Peirce Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Peirce Capital Management, LLC holds 412 shares of LLY stock, worth $324,734. This represents 0.18% of its overall portfolio holdings.

Number of Shares
412
Previous 412 -0.0%
Holding current value
$324,734
Previous $373 Million 2.15%
% of portfolio
0.18%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 02, 2024

SELL
$592.2 - $792.28 $19,542 - $26,145
-33 Reduced 7.42%
412 $321 Million
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $233,709 - $275,512
445 New
445 $259 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Peirce Capital Management, LLC Portfolio

Follow Peirce Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peirce Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peirce Capital Management, LLC with notifications on news.